Maize cytoplasmic male sterility (CMS) C-type restorer RF4 gene, molecular markers and their use

US10117411B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10117411-B2
Application numberUS-201113244049-A
CountryUS
Kind codeB2
Filing dateSep 23, 2011
Priority dateOct 6, 2010
Publication dateNov 6, 2018
Grant dateNov 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure concerns high-resolution mapping and candidate gene cloning of Rf4, a maize restorer of fertility gene that restores fertility to C-type cytoplasmic male sterility. The disclosure also relates to molecular markers that are tightly-linked to, or reside within, the Rf4 gene. In some embodiments, methods are provided whereby hybrid seeds may be produced from crosses of a male plant comprising nucleic acid molecular markers that are linked to or that reside within the Rf4 gene and a female plant carrying C-type CMS.

First claim

Opening claim text (preview).

What may be claimed is: 1. A maize plant comprising an Rf4 functional restorer gene for maize C-type cytoplasmic male sterility from restorer line XJH58, wherein the plant comprises a marker nucleotide sequence selected from the group consisting of Marker ID Nos. 1-50: B73 Chrom. 8 Position Marker ID No. Start Stop Marker 1 8885 8885 C 2 11684 11684 G 3 11883 11883 C 4 12831 12831 C 5 13168 13168 A 6 13171 13171 C 7 13179 13179 T 8 13191 13191 G 9 14191 14191 A 10 15309 15309 A 11 15639 15639 T 12 15735 15735 T 13 15744 15744 A 14 15790 15790 A 15 17395 17395 T 16 18749 18749 T 17 18796 18796 T 18 18798 18799 GC 19 19119 19119 A 20 22230 22230 T 21 22266 22266 C 22 41082 41082 C 23 41335 41335 C 24 41944 41944 T 25 44285 44285 C 26 44387 44387 T 27 45202 45202 — 28 46136 46136 A 29 46447 46447 G 30 46912 46912 T 31 46957 46957 A 32 46959 46959 T 33 46973 46973 C 34 46975 46975 A 35 46989 46989 G 36 47001 47001 C 37 47026 47026 A 38 65062 65063 — 39 65438 65438 GGT 40 66993 66993 A 41 79739 79739 A 42 82093 82093 T 43 85155 85155 A 44 85667 85667 A 45 85782 85784 — 46 86079 86079 A 47 86097 86097 TC 48 86113 86113 T 49 86247 86247 T 50 86653 86653  —,

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10117411B2 cover?
This disclosure concerns high-resolution mapping and candidate gene cloning of Rf4, a maize restorer of fertility gene that restores fertility to C-type cytoplasmic male sterility. The disclosure also relates to molecular markers that are tightly-linked to, or reside within, the Rf4 gene. In some embodiments, methods are provided whereby hybrid seeds may be produced from crosses of a male plant…
Who is the assignee on this patent?
Ren Ruihua, Nagel Bruce A, Kumpatla Siva P, and 5 more
What technology area does this patent fall under?
Primary CPC classification C12Q1/6895. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).